Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px
Document › Details

bioMérieux S.A.. (8/30/17). "Press Release: First-Half 2017 Results". Marcy l’Étoile.

Organisation Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
Products Product in vitro diagnostics (IVD)
  Product 2 molecular diagnostics
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)
     


> Solid sales dynamic, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation:
–– €1,134 million in sales
–– Up 13.3% as reported

> 30-bp improvement in contributive operating margin before non-recurring items, which came out at 15.2% of sales

> Sharp 18% increase in net income to €101 million

> 2017 financial targets revised:
–– Organic growth in sales of between 9% and 10%
–– Contributive operating income before non-recurring items of between €330 million and €345 million

Alexandre Mérieux, Chief Executive Officer, said: "bioMérieux has achieved very satisfactory sales and operating results for the first six months of the year. In light of this dynamic performance, as well as the more-favorable-than-expected currency environment, we are able to revise our full-year financial targets upward while pursuing our innovation and development efforts for the long term."

Download [ www.biomerieux.com/sites/corporate/files/news-event-press-release/biomerieux_pr_h1_2017_results.pdf ]




   
Record changed: 2017-09-06

Advertisement

Picture EBD Group Biotech Showcase 2019 San Francisco BTS January 600x60px

More documents for Mérieux (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px




» top